Positive control List multi. Picklist values: If applicable, indicate which substance(s) substance list with - 2-acetylaminofluorene was/were used as positive control(s). Multiple remarks) - triethylenemelamine items can be selected. If different substances - 3-methylcholanthrene were used for tests with and without metabolic Display: Basic - 4-nitroquinoline-N-oxide activation or for different tester strains or for the - 7,12-dimethylbenzanthracene different treatment harvest schedules, include a - 9,10-dimethylbenzanthracene remark in subfield 'Remarks'. - 9-aminoacridine - 2-nitrofluorene If other than the reference substance(s) specified - sodium azide in the test guidelines was/were used, include a - monomeric acrylamide brief justification. - N-dimethylnitrosamine - N-ethyl-N-nitro-N-nitrosoguanidine Final concentration, conditions and durations of - benzo(a)pyrene treatment and recovery periods. - congo red - colchicine Note that the list of substances provided is not - cumene hydroperoxide exhaustive. - cyclohexylamine - cyclophosphamide - cytosine arabinoside - ethylmethanesulphonate - ethylnitrosurea - furylfuramide - methylmethanesulfonate - mitomycin C - streptonigrin - vinblastine - other: - not specified Remarks Text (255 char.) Enter any remarks related to the recorded controls as appropriate. Display: Basic Controls of fields (repeatable) End Details on test Text template Freetext template: Use freetext template and delete/add elements as system and NUMBER OF REPLICATIONS: appropriate. Enter any details that could be experimental Display: Detailed - Number of cultures per concentration (single, relevant for evaluating this study summary or that conditions duplicate, triplicate) are requested by the respective regulatory - Number of independent experiments programme. Consult the programme-specific
Positive control substance List multi. list with remarks) Display: Basic Picklist values: - 2-acetylaminofluorene - triethylenemelamine - 3-methylcholanthrene - 4-nitroquinoline-N-oxide - 7,12-dimethylbenzanthracene - 9,10-dimethylbenzanthracene - 9-aminoacridine - 2-nitrofluorene - sodium azide - monomeric acrylamide - N-dimethylnitrosamine - N-ethyl-N-nitro-N-nitrosoguanidine - benzo(a)pyrene - congo red - colchicine - cumene hydroperoxide - cyclohexylamine - cyclophosphamide - cytosine arabinoside - ethylmethanesulphonate - ethylnitrosurea - furylfuramide - methylmethanesulfonate - mitomycin C - streptonigrin - vinblastine - other: - not specified If applicable, indicate which substance(s) was/were used as positive control(s). Multiple items can be selected. If different substances were used for tests with and without metabolic activation or for different tester strains or for the different treatment harvest schedules, include a remark in subfield 'Remarks'. If other than the reference substance(s) specified in the test guidelines was/were used, include a brief justification. Final concentration, conditions and durations of treatment and recovery periods. Note that the list of substances provided is not exhaustive. Remarks Text (255 char.) Display: Basic Enter any remarks related to the recorded controls as appropriate. Controls of fields (repeatable) End Details on test system and experimental conditions Text template Display: Detailed Freetext template: NUMBER OF REPLICATIONS: - Number of cultures per concentration (single, duplicate, triplicate) - Number of independent experiments Use freetext template and delete/add elements as appropriate. Enter any details that could be relevant for evaluating this study summary or that are requested by the respective regulatory programme. Consult the programme-specific
OHT%2070%20-%20ENDPOINT_STUDY_RECORD.GeneticToxicityVitro%20-version%207.0%20-Dec%202017.docx